Binding mechanism of rhaponticin and human serum albumin.
- Author:
Ming GUO
1
;
Xing-tao XU
;
Zhi-wu WU
Author Information
1. Department of Chemistry, Zhejiang Agriculture and Forestry University, Lin 'an 311300, China. guoming@zafu.edu.cn
- Publication Type:Journal Article
- MeSH:
Binding Sites;
Drug Interactions;
Energy Transfer;
Humans;
Hydrophobic and Hydrophilic Interactions;
Ions;
pharmacology;
Metals;
pharmacology;
Models, Molecular;
Protein Binding;
Protein Conformation;
Serum Albumin;
chemistry;
metabolism;
Spectrometry, Fluorescence;
Spectrophotometry, Ultraviolet;
Stilbenes;
chemistry;
metabolism
- From:
Acta Pharmaceutica Sinica
2011;46(9):1084-1092
- CountryChina
- Language:Chinese
-
Abstract:
The interaction mechanism between rhaponticin (RT) and human serum albumin (HSA) has been studied by fluorescence spectroscopy and absorbance spectra. The mediation effect that the metal ions took part in the interaction has also been discussed in this paper. Based on different theoretical models of fluorescence quenching, the binding constant (K) and binding sites (n) of the interaction were determined and analyzed comparatively. The quenching mechanism of the binding reaction has also been discussed. The binding distance (r) and energy-transfer efficiency (E) between RT/RT-Co(II)/RT-Ni(II) and HSA were also obtained by virtue of the Förster theory of non-radiation energy transfer. The effect of RT acting on the HSA's conformation was analyzed by synchronous fluorescence spectroscopy. The result showed that the result calculated by different theoretical models is generally equivalent and RT bound HSA strongly by forming stable complex, which indicates that HSA under physiological conditions can act as a carrier for RT to be transported to exert effects. The microconformation of HSA changed significantly due to hydrophobicity change in the chemical environment of some fluorescence chromophores in the subdomain IIA and IIB of HSA. Metal ions Co(II) and Ni(II) can mediate RT-HSA interaction, making the binding of the drug to protein stronger, which indicates that Co(II) and Ni(II) can enhance rhaponticin's medical efficacy under physiological conditions.
